Startup profile for Yazen: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Yazen funding, valuation and investors

Digital obesity-care platform combining weight-loss medication with multidisciplinary clinical support.

Keep track of Yazen

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Growth financing

€50 million · October 8, 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

Not publicly disclosed

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

growth · Lund, Sweden

Investors in latest funding

Lead: Verdane

Other: Evli Growth Partners

Sources: latest funding Last verified: 2026-10-09T02:03:00.000Z

Overview

Swedish digital healthcare provider treating obesity as a chronic disease through medication, continuous digital care, personal doctors, coaches, dietitians, psychologists and physiotherapists across eight European countries.

Why Yazen is interesting

Yazen is testing whether GLP-1-era weight management can become a durable longitudinal-care business rather than a prescription-acquisition channel.

Product & use cases

A digital obesity-care service that combines modern medication with ongoing care from a multidisciplinary clinical team.

Key facts

  • 50,000-plus active patients and 70,000-plus treated, according to the investor announcement.
  • Operates in Sweden, Norway, Denmark, the Netherlands, the UK, Germany, Switzerland and Spain.

Funding history (newest first)

Investors in our directory

Funds linked from Yazen's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: Yazen reports active operations in eight countries and combines prescribing with longitudinal clinical support; durability depends on adherence, outcomes and regulated-market execution.

Competes with digital obesity clinics, telehealth providers and pharmaceutical-supported weight-management programs. Differentiation rests on multidisciplinary care, retention and clinical evidence.

  • Neko Health adjacent

    European consumer health platform with different diagnostic focus.

  • WeightWatchers Clinic direct

    Scaled digital weight-management and prescribing service.

Industries

Market / IPO context

Editorial / static context — not a live quote.

Related funding articles

Venture Capital Tracker pieces that cover Yazen's financing or category context.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.